RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..8 of 8 - per page
Order by
Seeking development opportunities with novel delivery technologies for oral, topical and transdermal products
Delivery technologies for oral, topical and transdermal products which could be applicable to the consumer healthcare arena More
New Chemical Entities and innovative therapeutic targets
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
UK Marketing Partner
Are you a small to medium company seeking a UK presence? More
Acquisition of UK Hospital established brands
UK partner for strategic divestments More
Acquisition of UK Primary Care ethical brands
Strategic divestments of primary care sales focussed brands More
Rx and/or OTC Products for Gastroenterology Market
Seeking new technologies and/or existing products More
End of Phase III products for the treatment of irritable bowel syndrome (IBS) sought
The new product sought should act as complimentary product to our corporate pipeline product vedolizumab More
Displaying 1..8 of 8 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Gastrointestinal Disorders Therapy Area Pipeline Report
Nov 2010 - 933 pages - $1,495
Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report
Nov 2010 - 324 pages - $1,495
Deals and alliances in gastrointestinal diseases
Jun 2006 - 278 pages - $2,495
Hokkaido Gastrointestinal Cancer Study Group – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 30 pages - $500
Spanish Cooperative Group for Gastrointestinal Tumour Therapy – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 41 pages - $500
Spanish Cooperative Group for Gastrointestinal Tumour Therapy – Developmental Therapeutics Review – Q1 2011
Mar 2011 - 41 pages - $500
Gastrointestinal Drug Discoveries
Jan 2008 - 148 pages - $1,740
Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 40 pages - $500
Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) – Developmental Therapeutics Review – Q1 2011
Mar 2011 - 40 pages - $500
Gastrointestinal Stromal Tumors (GIST) - Pipeline Review, Q1 2011
Jan 2011 - 81 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us